GILEAD SCIENCES, INC. Business Combination, Acquisition Related Costs
GILEAD SCIENCES, INC. (GILD) reported Business Combination, Acquisition Related Costs of $33.09 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2013-02-27
- GILEAD SCIENCES, INC. business combination, acquisition related costs for the quarter ending 2012-12-31 was $15.29M, a 70.76% decline year-over-year.
- GILEAD SCIENCES, INC. business combination, acquisition related costs for the quarter ending 2011-12-31 was $52.30M.
- GILEAD SCIENCES, INC. business combination, acquisition related costs for fiscal 2012 was $33.09M, a 36.70% decline from fiscal 2011.
- GILEAD SCIENCES, INC. business combination, acquisition related costs for fiscal 2011 was $52.28M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|
| 2012-12-31 | $15.29M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $33.09M 10-K · filed 2013-02-27 | |
| 2012-09-30 | $17.80M 10-Q · filed 2012-11-06 | ||
| 2011-12-31 | $52.30M 10-Q · filed 2012-11-06 | $52.28M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |